Cell Based Assays
Date: | 18-Nov-13 to 19-Nov-13 |
Location: | London Marriott Hotel Grosvenor Square / London / United Kingdom |
Category: | Chemicals Healthcare & Pharmaceuticals Science Conferences & Trade Fairs |
Following on from our hugely successful Cell-Based Assays conference in 2012, this year's agenda will provide a global forum for senior level decision makers and those working within Cell-Based Assays to meet.
Highly accurate in-vitro practices are becoming absolutely vital as is looking at cost-effective assay development. Cell based assays now play an important role into the research pipeline, making a large percentage of total research time and is set to show considerable growth over the coming years.
Highly accurate in-vitro practices are becoming absolutely vital as is looking at cost-effective assay development. Cell based assays now play an important role into the research pipeline, making a large percentage of total research time and is set to show considerable growth over the coming years.
Visitors
There are currently 15 FDA approved kinase inhibitor drugs, but there currently remains a huge uncapped potential with these drugs as over 90% of the kinome is unknown. Novel assays have identified kinase targets, improved the function of kinase inhibitors and led to an acceleration in drug discovery with new inhibitor classes.
See at Cell Based Assays 2013 how HCA can be utilised in your pre-clinical toxicology procedures to give highly accurate data.
WHY ATTEND THIS EVENT:
• Hear the latest on Phenotypic screening; how target based screening is allowing for identification of small molecules
• See how you can implement a primary cell assay plan through a case study of SARdriving assay
• The latest in GPCR and other ion channel targeting pathways and how they are being used in the most recent drug discovery assays
• Adopt accelerated primary cell screening systems such as those utilised by GSK
See at Cell Based Assays 2013 how HCA can be utilised in your pre-clinical toxicology procedures to give highly accurate data.
WHY ATTEND THIS EVENT:
• Hear the latest on Phenotypic screening; how target based screening is allowing for identification of small molecules
• See how you can implement a primary cell assay plan through a case study of SARdriving assay
• The latest in GPCR and other ion channel targeting pathways and how they are being used in the most recent drug discovery assays
• Adopt accelerated primary cell screening systems such as those utilised by GSK
Exhibitors
Sponsorship and Exhibition Opportunities are available
To find out more contact Alia Malick - Director
On tel: +44 (0)20 7827 6168 or email: amalick@smi-online.co.uk
To find out more contact Alia Malick - Director
On tel: +44 (0)20 7827 6168 or email: amalick@smi-online.co.uk
EIN News
provides powerful, real-time media monitoring, news aggregation & syndication services. Read the latest news about this topic. See:
- Autism News Today
- Brain Cancer News Today
- Breast Cancer News Today
- Breastfeeding News Today
- CNES News Today
- Canadian Space Agency News Today
- Chemical Industry Today
- Conferences & Trade Shows Today
- Dental Industry Today
- Dietary Supplements News Today
- H1N1 News Today
- H7N9 Bird Flu News Today
- Health Insurance Exchanges News
- Healthcare Industry Today
- Healthcare Reform News Today
- Home Birth News Today
- JAXA News Today
- Lung Cancer News Today
- MERS News Today
- Malaria News Today
- Marijuana News Today
- Mesothelioma News Today
- NASA News Today
- Pharmaceutical Industry Today
- Planned Parenthood News Today
- Prostate Cancer News Today
- Research Reports News Today
- SARS News Today
- Science News Today
- Wellness News Today